Back to Search
Start Over
EP08.02-146 Proposal of Foretinib as Second-Line TKI after Capmatinib/Tepotinib Treatment Failure in NSCLC with MET Exon 14 Mutation
- Source :
- Journal of Thoracic Oncology; September 2022, Vol. 17 Issue: 9, Number 9 Supplement 1 pS472-S473, 2p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 15560864 and 15561380
- Volume :
- 17
- Issue :
- 9, Number 9 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Journal of Thoracic Oncology
- Publication Type :
- Periodical
- Accession number :
- ejs62017382
- Full Text :
- https://doi.org/10.1016/j.jtho.2022.07.829